Recent Developments in ROS-Based Nanotherapeutic Modalities in Preclinical Cancer Treatment

Author(s):  
Neha Suyog Potnis ◽  
Akbar Ali ◽  
Suchetan Pal
RSC Advances ◽  
2015 ◽  
Vol 5 (92) ◽  
pp. 75575-75588 ◽  
Author(s):  
Charlotta D. Mock ◽  
Brian C. Jordan ◽  
Chelliah Selvam

This review focuses on recent developments in the use of curcumin, curcumin analogues, and novel delivery systems as a preventive and therapeutic method for breast cancer treatment.


2015 ◽  
Vol 13 (2) ◽  
pp. 239-252 ◽  
Author(s):  
N. Vijayakameswara Rao ◽  
Hong Yeol Yoon ◽  
Hwa Seung Han ◽  
Hyewon Ko ◽  
Soyoung Son ◽  
...  

2021 ◽  
Vol 8 (3) ◽  
pp. 179-181
Author(s):  
Sankha Bhattacharya ◽  
Utkarsha Chhotulal Kuwar

Dendrimers holds potential in abating restrictions of other available treatments through the development of functionalized particles for targeted treatment. By developing functionalized particles for targeted treatment, dendrimers have the ability to reduce the limitations of other available therapies. Dendrimers have many advantages over other nanoparticles, making them perfect candidates for more efficient and targeted drug delivery. Dendrimers have the ability to deliver vast quantities of drugs to particular locations. They can also be used to monitor the progress of the procedure, giving them a theranostic capability that has never been seen before. Dendrimers show their potential applicability for effective cancer treatment for the near future. These article highlights the evolution timeline of dendrimers and various related aspects of the past four decades. These also involve the basic structure and information of dendrimers along with the current and future perspective. As a result, it is important to study dendrimers in order to keep up with recent developments.


2021 ◽  
Vol 11 ◽  
Author(s):  
Wesam Kooti ◽  
Hadi Esmaeili Gouvarchin Ghaleh ◽  
Mahdieh Farzanehpour ◽  
Ruhollah Dorostkar ◽  
Bahman Jalali Kondori ◽  
...  

The global rate of cancer has increased in recent years, and cancer is still a threat to human health. Recent developments in cancer treatment have yielded the understanding that viruses have a high potential in cancer treatment. Using oncolytic viruses (OVs) is a promising approach in the treatment of malignant tumors. OVs can achieve their targeted treatment effects through selective cell death and induction of specific antitumor immunity. Targeting tumors and the mechanism for killing cancer cells are among the critical roles of OVs. Therefore, evaluating OVs and understanding their precise mechanisms of action can be beneficial in cancer therapy. This review study aimed to evaluate OVs and the mechanisms of their effects on cancer cells.


2020 ◽  
Vol 3 (4) ◽  
pp. 165-171
Author(s):  
Kyaw Zaw Hein ◽  
Shuyang Yao ◽  
Siqing Fu

ABSTRACT Vaccines have been used to fight and protect against infectious diseases for centuries. With the emergence of immunotherapy in cancer treatment, researchers began investigating vaccines that could be used against cancer, especially against tumors that are resistant to conservative chemotherapy, surgery, and radiotherapy. The Wilms' tumor 1 (WT1) protein is immunogenic, has been detected in almost all types of malignancies, and has played a significant role in prognosis and disease monitoring. In this article, we review recent developments in the treatment of various types of cancers with the WT1 cancer vaccine; we also discuss theoretic considerations of various therapeutic approaches, which were based on preclinical and clinical data.


Author(s):  
Sushil Kumar Singh ◽  
Yudhishthir Singh Baghel ◽  
Sankha Bhattacharya

: Application of Pickering Emulsion is a new area for the cure of multiple human disorders, such as cancer. There is a minimal accomplishment in traditional treatment modalities for cancer, including surgery, radiation, radiotherapy, and immunotherapy. The emergence of Pickering emulsion in cancer therapeutics is new hope in cancer treatment. Over the last 15 years, increasing importance in Pickering Emulsions was witnessed, primarily due to their very desirable properties similar to ordinary emulsions, namely their excellent stability. The main agenda of this review was to address the advantages, disadvantages, characterization parameters, i.e., droplet size & stability, etc., opportunities, different development procedures of Pickering Emulsion for cancer diseases. This review also addressed the recent developments in technological problems of Pickering Emulsions. It examined the possible benefits and disadvantages of utilizing such formulations as an alternative to traditional surfactant-based methods for topical pharmaceutical and cosmetic applications. The evolution of Pickering Emulsion as a multifunctional dosage from carrier reflects a revived outlook for the pharmaceutical and cosmetic industries.


Sign in / Sign up

Export Citation Format

Share Document